Independence at the US Food and Drug Administration.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      The article discusses the acting commissioner for the Food and Drug Administration (FDA) in the United States, Andrew von Eschenbach, and his role in the decision making of the government agency to either approve or disapprove the emergency contraceptive Plan B for women over 16 years old. The U.S. Senate has prevented von Eschenbach from being commissioned until he makes a decision about the laws for obtaining the emergency contraceptive. The author writes that von Eschenbach's refusal to act undermines his own credibility as well as the agency's.